US Codex
Pub. L.
Notes

Division C — Health and Human Services

117th Congress · Approved Dec 16, 2022 · 136 Stat. 2308 · Lineage

DIVISION C Health and Human Services

TITLE I Medicare and Medicaid

SEC. 101. Extension of Increased Inpatient Hospital Payment Adjustment for Certain Low-Volume Hospitals.

(a)
In General.— Section 1886(d)(12) of the Social Security Act (42 U.S.C. 1395ww(d)(12)) is amended—
(1)
in subparagraph (B), in the matter preceding clause (i), by striking “ December 17, 2022” and inserting “ December 24, 2022”;
(2)
in subparagraph (C)(i)—
(A)
in the matter preceding subclause (I), by striking “ December 16, 2022” and inserting “ December 23, 2022”;
(B)
in subclause (III), by striking “ December 16, 2022’ ” and inserting “ December 23, 2022”; and
(C)
in subclause (IV), by striking “ December 17, 2022” and inserting “ December 24, 2022”; and
(3)
in subparagraph (D)—
(A)
in the matter preceding clause (i), by striking “ December 16, 2022’ ” and inserting “ December 23, 2022”; and
(B)
in clause (ii), by striking “ December 16, 2022’ ” and inserting “ December 23, 2022”.
(b)
Implementation.— Notwithstanding any other provision of law, the Secretary of Health and Human Services may implement the provisions of, including the amendments made by, this section by program instruction or otherwise.

SEC. 102. Extension of the Medicare-Dependent Hospital Program.

(a)
In General.— Section 1886(d)(5)(G) of the Social Security Act (42 U.S.C. 1395ww(d)(5)(G)) is amended—
(1)
in clause (i), by striking “ December 17, 2022” and inserting “ December 24, 2022”; and
(2)
in clause (ii)(II), by striking “ December 17, 2022” and inserting “ December 24, 2022”.
(b)
Conforming Amendments.—
(1)
Extension of target amounts.— Section 1886(b)(3)(D) of the Social Security Act (42 U.S.C. 1395ww(b)(3)(D)) is amended—
(A)
in the matter preceding clause (i), by striking “ December 17, 2022” and inserting “ December 24, 2022”; and
(B)
in clause (iv), by striking “ December 16, 2022,” and inserting “ December 23, 2022”.
(2)
Permitting hospitals to decline reclassification.— Section 13501(e)(2) of the Omnibus Budget Reconciliation Act of 1993 (42 U.S.C. 1395ww note) is amended by striking “ December 16, 2022” and inserting “ December 23, 2022”.

SEC. 103. Extension of Increased Fmaps under Medicaid for the Territories.

Section 1905(ff) of the Social Security Act (42 U.S.C. 1396d(ff)) is amended—
(1)
in paragraph (2), by striking “ December 16, 2022” and inserting “ December 23, 2022”; and
(2)
in paragraph (3), by striking “ December 16, 2022” and inserting “ December 23, 2022”.

SEC. 104. Medicare Improvement Fund.

Section 1898(b)(1) of the Social Security Act (42 U.S.C. 1395iii(b)(1)) is amended by striking “ $7,308,000,000” and inserting “ $7,278,000,000”.

TITLE II Human Services

SEC. 201. Extension of Maternal, Infant, and Early Childhood Home Visiting Programs.

Activities authorized by section 511 of the Social Security Act shall continue through December 23, 2022, and out of any money in the Treasury of the United States not otherwise appropriated, there is hereby appropriated for such purpose an amount equal to the pro rata portion of the amount appropriated for such activities for fiscal year 2022.

SEC. 202. Extension of Child and Family Services Programs.

Activities authorized by part B of title IV of the Social Security Act shall continue through December 23, 2022, in the manner authorized for fiscal year 2022, and out of any money in the Treasury of the United States not otherwise appropriated, there are hereby appropriated such sums as may be necessary for such purpose.

TITLE III Extension of Fda Authorizations

SEC. 301. Reauthorization of the Critical Path Public-Private Partnership.

Section 566(f) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360bbb–5(f)) is amended by striking “ $1,265,753 for the period beginning on October 1, 2022 and ending on December 16, 2022” and inserting “ $1,380,822 for the period beginning on October 1, 2022 and ending on December 23, 2022”.

SEC. 302. Reauthorization of the Best Pharmaceuticals for Children Program.

Section 409I(d)(1) of the Public Health Service Act (42 U.S.C. 284m(d)(1)) is amended by striking “ $5,273,973 for the period beginning on October 1, 2022 and ending on December 16, 2022” and inserting “ $5,753,425 for the period beginning on October 1, 2022 and ending on December 23, 2022”.

SEC. 303. Reauthorization of the Humanitarian Device Exemption Incentive.

Section 520(m)(6)(A)(iv) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360j(m)(6)(A)(iv)) is amended by striking “ December 17, 2022” and inserting “ December 24, 2022”.

SEC. 304. Reauthorization of the Pediatric Device Consortia Program.

Section 305(e) of the Pediatric Medical Device Safety and Improvement Act of 2007 (Public Law 110–85; 42 U.S.C. 282 note) is amended by striking “ $1,107,534 for the period beginning on October 1, 2022, and ending on December 16, 2022” and inserting “ $1,610,959 for the period beginning on October 1, 2022 and ending on December 23, 2022”.

SEC. 305. Reauthorization of Provision Pertaining to Drugs Containing Single Enantiomers.

Section 505(u)(4) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 355(u)(4)) is amended by striking “ December 17, 2022” and inserting “ December 24, 2022”.

SEC. 306. Reauthorization of Certain Device Inspections.

Section 704(g)(11) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 374(g)(11)) is amended by striking “ December 17, 2022” and inserting “ December 24, 2022”.

SEC. 307. Reauthorization of Orphan Drug Grants.

Section 5(c) of the Orphan Drug Act (21 U.S.C. 360ee(c)) is amended by striking “ $6,328,767 for the period beginning on October 1, 2022, and ending on December 16, 2022” and inserting “ $6,904,110 for the period beginning on October 1, 2022 and ending on December 23, 2022”.

SEC. 308. Reauthorization of Reporting Requirements Related to Pending Generic Drug Applications and Priority Review Applications.

Section 807 of the FDA Reauthorization Act of 2017 (Public Law 115–52) is amended, in the matter preceding paragraph (1), by striking “ December 16, 2022” and inserting “ December 23, 2022”.

SEC. 309. Reauthorization of Third-Party Review Program.

Section 523(c) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360m(c)) is amended by striking “ December 17, 2022” and inserting “ December 24, 2022”.

TITLE IV Indian Health

SEC. 401. Extension of Moratorium.

Section 424(a) of title IV of division G of Public Law 113–76 is amended by striking “ December 16, 2022” and inserting “ December 24, 2022”.